4th Annual Next Gen Immuno-Oncology Virtual Congress: Humanized Immune Checkpoint Mice Improve Translatability of Novel Immunotherapies

4th Annual Next Gen Immuno-Oncology Virtual Congress: Humanized Immune Checkpoint Mice Improve Translatability of Novel Immunotherapies

Speaker: Jenna Frame, Senior Scientist, Scientific Communications

  • Mice expressing human immune checkpoints can serve as powerful preclinical models to evaluate the in vivo efficacy of anti-human antibody candidates for immuno-oncology targets.
  • Biocytogen’s humanized mice have been carefully designed and subjected to rigorous validation to ensure the integrity of immune responses. 
  • Biocytogen’s humanized CD3E & CD3EDG models allow for broader targeting of the entire CD3 complex with novel mono- &  bispecific antibody therapeutics

Share:

Please fill out the form below to request a download of this Webinar